
Evonik Invests $100 Million in U.S. API Production
Evonik is modernizing the API production at its Tippecanoe site in the U.S. Over the next five years, the company will invest $100 million in upgrading key plant components.

Evonik is modernizing the API production at its Tippecanoe site in the U.S. Over the next five years, the company will invest $100 million in upgrading key plant components.

Röhm is driving international growth with a new methacrylate production facility in Texas.

Budenheim Life Sciences is expanding its preventive and specialized nutrition portfolio in the Americas with the launch of a chelated minerals portfolio.

How Resilience, Reliability, and Innovation are Reshaping Specialty Chemicals Manufacturing in the US














